Virus and host determinants of West Nile virus pathogenesis

PLoS Pathogens

Volumn 5, Issue 6, 2009, Pages

  Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE RECEPTOR CCR5; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; 2',5' OLIGOADENYLATE SYNTHETASE; INTERFERON;

AMINO ACID SUBSTITUTION; BIRD DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE PRODUCTION; EPIDEMIC; GENETIC RISK; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION RISK; NONHUMAN; REVIEW; TOGAVIRUS INFECTION; VIREMIA; VIRUS GENOME; VIRUS MUTATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; ANIMAL; ARTICLE; BRAIN; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS INFECTION;

WEST NILE VIRUS;

2',5'-OLIGOADENYLATE SYNTHETASE; AMINO ACID SUBSTITUTION; ANIMALS; BRAIN; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERONS; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 67650908896     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000452     Document Type: Review

References (23)

1. Brault AC, Huang CY, Langevin SA, Kinney RM, Bowen RA, et al. (2007) A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet 39: 1162-1166.
2. Moudy RM, Meola MA, Morin LL, Ebel GD, Kramer LD (2007) A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg 77: 365-370.
3. Kilpatrick AM, Meola MA, Moudy RM, Kramer LD (2008) Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 4: e1000092. doi:10.1371/journal.ppat.1000092.
4. Diamond MS, Pierson TC, Fremont DH (2008) The structural immunology of antibody protection against West Nile virus. Immunol Rev 225: 212-225.
5. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ (2003) Structure of West Nile virus. Science 302: 248.
6. Nelson S, Jost CA, Xu Q, Ess J, Martin JE, et al. (2008) Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog 4: e1000060. doi:10.1371/journal.ppat.1000060. (Pubitemid 351811531)
7. Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, et al. (2006) Antibodies against West Nile virus non-structural (NS)-1 protein prevent lethal infection through Fc gamma receptor-dependent and independent mechanisms. J Virol 80: 1340-1351. (Pubitemid 43134091)
8. McGavern DB, Homann D, Oldstone MB (2002) T cells in the central nervous system: the delicate balance between viral clearance and disease. J Infect Dis 186 Suppl 2: S145-S151. (Pubitemid 35370474)
9. Shrestha B, Diamond MS (2004) The role of CD8+ T cells in the control of West Nile virus infection. J Virol 78: 8312-8321. (Pubitemid 38944315)
10. Sitati E, Diamond MS (2006) CD4+ T Cell responses are required for clearance of West Nile Virus from the central nervous system. J Virol 80: 12060-12069. (Pubitemid 44904356)
11. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, et al. (2006) Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 1325-1332. (Pubitemid 44614956)
12. Wang Y, Lobigs M, Lee E, Koskinen A, Mullbacher A (2006) CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon. J Gen Virol 87: 3599-3609. (Pubitemid 44822017)
13. Chan-Tack KM, Forrest G (2005) Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis. Scand J Infect Dis 37: 944-946. (Pubitemid 43078114)
14. Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, et al. (2006) A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol 80: 2396-2404. (Pubitemid 43271545)
15. Scholle F, Mason PW (2005) West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology 342: 77-87. (Pubitemid 41531987)
16. Wilson JR, de Sessions PF, Leon MA, Scholle F (2008) West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol 82: 8262-8271.
17. Fredericksen BL, Gale M Jr (2006) West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol 80: 2913-2923.
18. Guo JT, Hayashi J, Seeger C (2005) West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 79: 1343-1350. (Pubitemid 40459081)
19. Mackenzie JM, Khromykh AA, Parton RG (2007) Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2: 229-239.
20. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, et al. (2005) Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79: 8004-8013. (Pubitemid 40853504)
21. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, et al. (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202: 1087-1098. (Pubitemid 41464502)
22. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, et al. (2006) CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203: 35-40. (Pubitemid 43139642)
23. Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, et al. (2009) Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 5: e1000321. doi:10.1371/journal.ppat.1000321.